Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 10:20 AM
NCT ID: NCT01485861
Term: VOMITING
Organ System: Gastrointestinal disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA18.1/23.1/25.1
Notes: None
Study: NCT01485861
Study Brief: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 14 9 14 View
EG001 3 3 6 View
EG002 42 27 84 View
EG003 69 24 88 View
EG004 24 12 81 View
EG005 12 5 25 View